HIV and infections of similar transmission patterns in a drug injectors community of Santos, Brazil

被引:54
作者
deCarvalho, HB
Mesquita, F
Massad, E
Bueno, RC
Lopes, GT
Ruiz, MA
Burattini, MN
机构
[1] UNIV SAO PAULO,NUPAIDS,BR-05508 SAO PAULO,BRAZIL
[2] IEPAS,SANTOS,BRAZIL
[3] SECRETARIA ESTADO SAUDE SAO PAULO,SAO PAULO,BRAZIL
[4] ESCOLA PAULISTA MED,DISCIPLINA DOENCAS INFECC,SAO PAULO,BRAZIL
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1996年 / 12卷 / 01期
关键词
HIV; HTLV (1 and 2); hepatitis B; hepatitis C; syphilis; injecting drug users; cocaine; Brazil;
D O I
10.1097/00042560-199605010-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the prevalence of HIV and infections with related transmission patterns, we interviewed and obtained blood samples from 110 injecting drug users (IDUs), sampled by snowballing, from the city of Santos in the state of Sao Paulo, Brazil, where the estimated number of IDUs (10,000) comprises similar to 2% of the entire population. Seroprevalence of HIV, hepatitis B and C. syphilis, and HTLV (1 and 2) was assessed and compared with that in 197 blood donors from the same city, matched for age and gender. Risk behavior related to HIV was assessed by a standard questionnaire applied to the IDU sample. Univariate and multivariate analyses of the risk factors were performed. Seroprevalences found were 62% for HIV, 75% for HCV. 75% for HBV, 34% for syphilis, and 25% for HTLV (1 and 2) among IDUs, which compare with 0.0%, 2%, 23%, 12%, and 1% for blood donors, respectively. The risk for parenterally transmitted infections in this IDU community was higher than that for sexually transmitted infections (odds ratio for syphilis, 3.57; hepatitis B. 10.0: and hepatitis C, 100). The results of the multivariate risk analysis showed that daily rate of ID use >5 times/day (OR = 6.73), not changing behavior to avoid AIDS (OR = 3.28), ID use >15 days/month (OR = 2.72), and ID use in the last 2 months (OR = 2.23) were the risk behaviors significantly associated with HIV infection.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 30 条
  • [1] Andrade AL, 1989, REV SAUDE PUBL, V23, P205, DOI DOI 10.1590/S0034-89101989000100004
  • [2] PROPHYLACTIC VACCINES, RISK BEHAVIOR-CHANGE, AND THE PROBABILITY OF ERADICATING HIV IN SAN-FRANCISCO
    BLOWER, SM
    MCLEAN, AR
    [J]. SCIENCE, 1994, 265 (5177) : 1451 - 1454
  • [3] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [4] DETECTION OF ANTIBODIES TO HEPATITIS-C VIRUS IN UNITED-STATES BLOOD-DONORS
    DAWSON, GJ
    LESNIEWSKI, RR
    STEWART, JL
    BOARDWAY, KM
    GUTIERREZ, RA
    PENDY, L
    JOHNSON, RG
    ALCALDE, X
    ROTE, KV
    DEVARE, SG
    ROBEY, WG
    PETERSON, DA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (03) : 551 - 556
  • [5] DEAN AG, 1990, EPIINFO VERSION 5 WO
  • [6] Des Jarlais D. C., 1994, Scientific American, V270, P56
  • [7] Esteban JL, 1992, BLOOD SAFETY CURRENT, P45
  • [8] HCV CONFIRMATORY TESTING OF BLOOD-DONORS
    FOLLETT, EAC
    DOW, BC
    MCOMISH, F
    YAP, PL
    HUGHES, W
    MITCHELL, R
    SIMMONDS, P
    [J]. LANCET, 1991, 338 (8773) : 1024 - 1024
  • [9] ANTIBODIES TO HEPATITIS-C VIRUS IN LOW-RISK BLOOD-DONORS - IMPLICATIONS FOR COUNSELING POSITIVE DONORS
    HSU, HH
    GONZALEZ, M
    FOUNG, SKH
    FEINSTONE, SM
    GREENBERG, HB
    [J]. GASTROENTEROLOGY, 1991, 101 (06) : 1724 - 1727
  • [10] AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS
    KUO, G
    CHOO, QL
    ALTER, HJ
    GITNICK, GL
    REDEKER, AG
    PURCELL, RH
    MIYAMURA, T
    DIENSTAG, JL
    ALTER, MJ
    STEVENS, CE
    TEGTMEIER, GE
    BONINO, F
    COLOMBO, M
    LEE, WS
    KUO, C
    BERGER, K
    SHUSTER, JR
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 362 - 364